Literature DB >> 19950966

Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding.

Masanori Miyata1, Takashi Sato, Mineyuki Mizuguchi, Teruya Nakamura, Shinji Ikemizu, Yuko Nabeshima, Seiko Susuki, Yoshiaki Suwa, Hiroshi Morioka, Yukio Ando, Mary Ann Suico, Tsuyoshi Shuto, Tomoaki Koga, Yuriko Yamagata, Hirofumi Kai.   

Abstract

Transthyretin (TTR) is a tetrameric protein associated with amyloidosis caused by tetramer dissociation and monomer misfolding. The structure of two TTR variants (E54G and E54K) with Glu54 point mutation that cause clinically aggressive amyloidosis remains unclear, although amyloidogenicity of artificial triple mutations (residues 53-55) in beta-strand D had been investigated. Here we first analyzed the crystal structures and biochemical and biophysical properties of E54G and E54K TTRs. The direction of the Lys15 side chain in E54K TTR and the surface electrostatic potential in the edge region in both variants were different from those of wild-type TTR. The presence of Lys54 leads to destabilization of tetramer structure due to enhanced electrostatic repulsion between Lys15 of two monomers. Consistent with structural data, the biochemical analyses demonstrated that E54G and E54K TTRs were more unstable than wild-type TTR. Furthermore, the entrance of the thyroxine (T(4)) binding pocket in TTR was markedly narrower in E54K TTR and wider in E54G TTR compared with wild-type TTR. The tetramer stabilization and amyloid fibril formation assays in the presence of T(4) showed lower tetramer stability and more fibril formation in E54K and E54G TTRs than in wild-type TTR, suggesting decreased T(4) binding to the TTR variants. These findings indicate that structural modification by Glu54 point mutation may sufficiently alter tetramer stability and T(4) binding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19950966     DOI: 10.1021/bi901677z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Experimentally derived structural constraints for amyloid fibrils of wild-type transthyretin.

Authors:  David A Bateman; Robert Tycko; Reed B Wickner
Journal:  Biophys J       Date:  2011-11-15       Impact factor: 4.033

2.  A Missense Variant p.Ala117Ser in the Transthyretin Gene of a Han Chinese Family with Familial Amyloid Polyneuropathy.

Authors:  Qian Chen; Lamei Yuan; Xiong Deng; Zhijian Yang; Shengwang Zhang; Sheng Deng; Hongwei Lu; Hao Deng
Journal:  Mol Neurobiol       Date:  2017-07-31       Impact factor: 5.590

3.  Hydrogen-bond network and pH sensitivity in human transthyretin.

Authors:  Takeshi Yokoyama; Mineyuki Mizuguchi; Yuko Nabeshima; Katsuhiro Kusaka; Taro Yamada; Takaaki Hosoya; Takashi Ohhara; Kazuo Kurihara; Ichiro Tanaka; Nobuo Niimura
Journal:  J Synchrotron Radiat       Date:  2013-09-29       Impact factor: 2.616

Review 4.  The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism.

Authors:  Chiara Sanguinetti; Marianna Minniti; Vanessa Susini; Laura Caponi; Giorgia Panichella; Vincenzo Castiglione; Alberto Aimo; Michele Emdin; Giuseppe Vergaro; Maria Franzini
Journal:  Biomedicines       Date:  2022-08-06

5.  Self-assembly of pyridine-modified lipoic Acid derivatives on gold and their interaction with thyroxine (t4).

Authors:  Willem M Albers; Roberto Milani; Kirsi Tappura; Tony Munter; Giuseppe Resnati; Pierangelo Metrangolo
Journal:  Int J Mol Sci       Date:  2013-02-06       Impact factor: 5.923

6.  Transthyretin Amyloid Fibril Disrupting Activities of Extracts and Fractions from Juglans mandshurica Maxim. var. cordiformis (Makino) Kitam.

Authors:  Niraj Chaudhary; Ryoko Sasaki; Tsuyoshi Shuto; Masato Watanabe; Teppei Kawahara; Mary Ann Suico; Takeshi Yokoyama; Mineyuki Mizuguchi; Hirofumi Kai; Hari Prasad Devkota
Journal:  Molecules       Date:  2019-01-30       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.